This study aims to demonstrate that bupivacaine administered rectally could be a step in between the current treatment options for intractable cancer pain, and to evaluate the effect of the mode of administration on the bupivacaine plasma concentration.

Bupivacaine in boluses administered intrathecally provided effective, safe analgesia in advanced cancer patients.

This article originally appeared on Cancer Therapy Advisor

READ FULL ARTICLE Curated publisher From Mdlinx